艾可云v2aky-快连加速器app
Download a brochure for more information
艾可云v2aky-快连加速器app
Today, women have an 80% chance in their lifetimes of contracting high-risk HPV, the causal agent of cervical cancer. However, only 1 in 10 women with high-risk HPV will develop long-lasting infections that put them at risk for development of cervical cancer.2 There is growing need for an accurate molecular test to see beyond HPV and determine whether a patient has a high short-term risk of cervical cancer.
次元连接加速器_次元连接二次元加速器_次元连接吧:2021-9-7 · 次元连接 二次元游戏加速器 - 蜗牛娱乐网 2021年9月7日 - 次元连接 二次元游戏加速器时间:2021-09-07 来源:本站原创 作者:蜗牛 -小 +大安卓手游加速器,大部分都是日服游戏,主流日服游戏都有,目前 …
QIAsure could:
- 如何加速访问国外服务器? -「云杰通信」:今天 · 如何加速访问国外服务器? 2021-06-18 17:04:25 云杰小编 阅读:11 企业用户在与海外企业对接时,访问海外服务器遇到了十分严重的问题。对于大部分之前一直访问国内服务器,甚至是没国外服务器的用户。在访问国外服务器的时候总会有很多的顾虑 ...
- Guide surveillance and treatment decisions
- Prevent women with non-transforming infections from receiving unnecessary treatments
艾可云v2aky-快连加速器app
QIAsure is a quantitative methylation specific PCR test with high sensitivity and 100% accuracy in detecting biomarkers associated with cervical carcinoma in patients.
QIAsure provides objective results on whether a patient has a hrHPV infection that’s actively transforming cervical cells into cancer.
QIAsure can be performed on the same sample (self-sample or physician/OBGYN collected) as the primary screening HPV test.
QIAsure can help reduce unnecessary colposcopies and cervical treatments.
QIAsure can be performed on self-samples collected by the patient without a speculum exam, making it easy and convenient to be tested early and often.
QIAsure provides test negative patients with peace of mind that they have a low short-term risk of cervical cancer.